Oct 2026· Journal of Clinical Research in Pediatric Endocrinology· 0 citations
Medicine
TL;DR
Adiposity-related parameters and dyslipidemia appear to be important clinical features associated with hepatic steatosis in pediatric T1DM, which had a higher prevalence of CAP-based hepatic steatosis/MASLD than healthy controls.
Abstract
Objective
This study aimed to determine the prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) in children and adolescents with type 1 diabetes mellitus (T1DM) using vibration-controlled transient elastography (VCTE), and to evaluate associated clinical and laboratory features.
Methods
This cross-sectional study included 72 children with T1DM and 83 healthy controls who were comparable in age and sex. Hepatic steatosis was assessed using ultrasonography and VCTE. A controlled attenuation parameter (CAP) value >236 dB/m was used to define CAP-based hepatic steatosis/MASLD in the T1DM group. Clinical, anthropometric, laboratory, and radiological characteristics were compared between groups. Correlations of CAP and liver stiffness measurement (LSM) with clinical and laboratory parameters were evaluated in the T1DM cohort. Stepwise multivariable linear regression analyses were performed to identify candidate factors independently associated with CAP and LSM values.
Results
CAP-based hepatic steatosis/MASLD was more frequent in children with T1DM than in controls (31.9% vs. 14.5%). Among children with T1DM, those with MASLD had higher body mass index, WHtR, diastolic blood pressure, and triglyceride levels than those without MASLD. In the multivariable CAP model, diabetes duration, low-density lipoprotein cholesterol, and WHtR were independently associated with higher CAP values. WHtR and alanine aminotransferase were independently associated with higher LSM values.
Conclusion
Children and adolescents with T1DM had a higher prevalence of CAP-based hepatic steatosis/MASLD than healthy controls. Adiposity-related parameters and dyslipidemia appear to be important clinical features associated with hepatic steatosis in pediatric T1DM.
Obesity, diabetes, and metabolic syndrome are becoming increasingly prevalent in Saudi Arabia, and therefore, raising concerns about metabolic dysfunction-associated steatotic liver disease (MASLD), metabolic steatohepatitis (MASH), and related cardiovascular complications. This study compared the occurrence of a...
Reem K. AlManea, Kossay El-Abd, Sara H. Alsinan et al.· Journal of Family and Commun...· 0 citations
Abdominal adiposity identifies steatosis risk in a graded manner but does not discriminate fibrosis, supporting adiposity- and sex-informed hepatic phenotyping in patients with T2DM.
S. Corrao, S. Scibetta, Brenda Bongiorno et al.· Acta Diabetologica· 0 citations
The findings endorse the need for screening for liver fibrosis in T2DM patients, particularly those at increased risk, and suggest early detection and appropriate management are essential to prevent progression to advanced liver disease.
M. Almohammadi, Z. E. Alsadi, A. B. Alenezi et al.· PeerJ· 0 citations
Background: Metabolic dysfunction-associated steatotic liver disease (MASLD) is a multisystem cardiometabolic condition. Because cardiometabolic abnormalities are components of the diagnostic framework, studies describing their prevalence in MASLD must distinguish phenotypic characterization from criterion-independent...
Nebyu Yonas Shanka, T. Tadesse· IgMin Research· 0 citations